Protocols
1 protocol(s) meet the specified criteria
Drug: ERIBULIN
Protocol No.TitleStatus
RU011201IA Randomized Phase III Trial of Eribulin Compared to Standard Weekly Paclitaxel as First- or Second-Line Therapy for Locally Recurrent or Metastatic Breast CancerOpen